Skip to main content
Equibles

D. E. Shaw & Co., Inc.

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1009207 New York, NY
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$103,558,747
+$44,747,758 QoQ
Shares Held
3,949,609
+58.2% QoQ
Ownership
3.14%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#10
of 271 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 217 Biotechnology names. ARQT ranks #15 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 5,877,959 $626,707,987
2 ALNY
Alnylam Pharmaceuticals, Inc.
 1,104,109 $332,369,932
3 EXEL
Exelixis, Inc.
 5,551,747 $302,070,554
4 BBIO
BridgeBio Pharma, Inc.
 3,633,007 $270,586,360
5 TGTX
Tg Therapeutics, Inc.
 3,400,808 $186,840,390
6 HALO
Halozyme Therapeutics, Inc.
 2,006,479 $157,047,110
7 AXSM
Axsome Therapeutics, Inc.
 604,753 $148,025,391
8 PTCT
Ptc Therapeutics, Inc.
 1,548,919 $126,345,322

All Filings in ARQT

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $103,558,747 3,949,609
2026-03-31 $58,810,989 2,496,222
2025-12-31 $77,916,846 2,683,087
2025-09-30 $39,937,740 2,118,713
2025-06-30 $30,325,273 2,163,001
2025-03-31 $31,115,904 1,989,508
2024-12-31 $35,014,126 2,513,577
2024-09-30 $16,228,723 1,745,024
2024-06-30 $9,368,671 1,007,384
2024-03-31 $2,149,142 216,866
2023-03-31 $116,919 10,629
2022-12-31 $550,204 37,176
2022-09-30 $1,421,325 74,376
2020-06-30 $288,671 9,546